Show simple item record

dc.contributor.authorLahera, Guillermo
dc.contributor.authorGálvez, José L.
dc.contributor.authorSánchez Gómez, Pedro María ORCID
dc.contributor.authorMartínez-Roig, Miguel
dc.contributor.authorPérez-Fuster, J. V.
dc.contributor.authorGarcía-Portilla, Paz
dc.contributor.authorHerrera, Berta
dc.contributor.authorRoca, Miquel
dc.date.accessioned2019-04-05T07:25:58Z
dc.date.available2019-04-05T07:25:58Z
dc.date.issued2018-06-05
dc.identifier.citationBMC Psychiatry 18 : (2018) // Article ID 176es_ES
dc.identifier.issn1471-244X
dc.identifier.urihttp://hdl.handle.net/10810/32343
dc.description.abstractemission and encompasses multiple aspects of the patient's life, making it difficult to settle on a definition and to develop reliable assessment criteria. In this consensus process based on a panel of experts in schizophrenia, we aimed to provide useful insights on functional recovery and its involvement in clinical practice and clinical research. Methods: After a literature review of functional recovery in schizophrenia, a scientific committee of 8 members prepared a 75-item questionnaire, including 6 sections: (I) the concept of functional recovery (9 items), (II) assessment of functional recovery (23 items), (III) factors influencing functional recovery (16 items), (IV) psychosocial interventions and functional recovery (8 items), (V) pharmacological treatment and functional recovery (14 items), and (VI) the perspective of patients and their relatives on functional recovery (5 items). The questionnaire was sent to a panel of 53 experts, who rated each item on a 9-point Liken scale. Consensus was achieved in a 2-round Delphi dynamics, using the median (interquartile range) scores to consider consensus in either agreement (scores 7-9) or disagreement (scores 1-3). Items not achieving consensus in the first round were sent back to the experts for a second consideration. Results: After the two recursive rounds, consensus was achieved in 64 items (85.3%): 61 items (81.3%) in agreement and 3 (4.0%) in disagreement all of them from section II (assessment of functional recovery). Items not reaching consensus were related to the concepts of functional recovery (1 item, 13%), functional assessment (5 items, 6.7%), factors influencing functional recovery (3 items, 4.0%), and psychosocial interventions (2 items, 5.6%). Conclusions: Despite the lack of a well-defined concept of functional recovery, we identified a trend towards a common archetype of the definition and factors associated with functional recovery, as well as its applicability in clinical practice and clinical research.es_ES
dc.description.sponsorshipThis project was funded by Janssen. The funding body participated in study design and data interpretation.es_ES
dc.language.isoenges_ES
dc.publisherBiomed Centrales_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectschizophreniaes_ES
dc.subjectfunctional recoveryes_ES
dc.subjectpsychosocial therapyes_ES
dc.subjectantipsychotic agentses_ES
dc.subjectfollow-upes_ES
dc.subjectschizoaffective disorderes_ES
dc.subject1st-episode psychosises_ES
dc.subjectmaintenance treatmentes_ES
dc.subjectnegative symptomses_ES
dc.subjectfamily treatmentes_ES
dc.subjectdose reductiones_ES
dc.subjectpeoplees_ES
dc.titleFunctional recovery in patients with schizophrenia: recommendations from a panel of expertses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-018-1755-2es_ES
dc.identifier.doi10.1186/s12888-018-1755-2
dc.departamentoesMedicinaes_ES
dc.departamentoeuMedikuntzaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Except where otherwise noted, this item's license is described as This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.